Inhibrx Biosciences, Inc.

Home
United States
La Jolla, CA
Inhibrx Biosciences, Inc.

At Inhibrx, our mission is to deliver optimized, biologic therapeutics to people with life-threatening conditions.

06/17/2026

June is Cancer Immunotherapy Awareness Month, a time to recognize the importance of continued research in immunotherapy for patients facing cancer.

Learn more about how Inhibrx is contributing to oncology research through our investigational programs: https://tinyurl.com/catfc3pt

06/15/2026

Inhibrx is pleased to share that the U.S. FDA has accepted for filing its Biologics License Application (BLA) seeking approval of ozekibart (INBRX-109) for the treatment of patients with unresectable or metastatic conventional chondrosarcoma.

Read the full press release on our website: https://tinyurl.com/2mrfcssw

06/11/2026

This National Cancer Survivors Month, we honor those navigating cancer survivorship and the strength carried through every stage of that journey.

Their experiences reinforce the importance of continued research and scientific progress across oncology.

Learn more about our oncology research: https://tinyurl.com/catfc3pt

05/31/2026

Our team is onsite at the 2026 ASCO Annual Meeting and looking forward to engaging with the oncology community.

Stop by our booth (Booth #37116) to learn more about our ongoing research programs and commitment to advancing potential new treatment options for patients.

05/22/2026

Inhibrx is heading to the 2026 ASCO Annual Meeting, where updated data in chondrosarcoma and colorectal cancer from the ozekibart (INBRX-109) program will be presented.

Visit our medical booth ( #37116) to connect with our team and learn more about our ongoing research.

05/11/2026

Inhibrx is excited to share a clinical update on INBRX-106 in first-line head and neck cancer.

Read the full press release on our website here: https://inhibrxbiosciences.investorroom.com/2026-05-11-Inhibrx-Reports-Interim-Phase-2-Data-for-INBRX-106-in-First-Line-HNSCC-Initial-Results-Demonstrate-Potential-Costimulatory-Benefit-Over-PD-1-Monotherapy?utm_source=facebook&utm_medium=social&utm_campaign&utm_content=ap_pmfis2s4kb

05/05/2026

National Cancer Research Month is a reminder that progress in oncology depends on continued scientific discovery.

Research plays an essential role in improving our understanding of cancer and advancing new approaches for patients and communities affected by these diseases.

Learn more about our oncology research: https://tinyurl.com/jrkxavnx

05/01/2026

We remain committed to pursuing science that may help address significant unmet needs and contribute to the future of treatment innovation.

Progress in childhood cancers depends on continued research, collaboration, and determination—and we are proud to be part of that effort with our ozekibart program in Ewing sarcoma.

Learn more about our ongoing research in Ewing sarcoma with our ozekibart (INBRX-109) program: https://tinyurl.com/6w46a4hm

04/29/2026

Inhibrx was pleased to partner with the Linda Vista Innovation Center by welcoming military-connected students from the Chula Vista Elementary School District to our office for a field trip as part of their biotech camp.

The visit gave students a chance to experience a professional science working environment as part of a design-thinking challenge connected to their labs.

We are grateful to support programs that foster learning, spark creativity, and introduce students to future STEM opportunities.

04/24/2026

“𝘛𝘩𝘦 𝘴𝘵𝘳𝘦𝘯𝘨𝘵𝘩 𝘰𝘧 𝘰𝘶𝘳 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘪𝘴 𝘳𝘰𝘰𝘵𝘦𝘥 𝘪𝘯 𝘵𝘩𝘦 𝘴𝘵𝘳𝘦𝘯𝘨𝘵𝘩 𝘰𝘧 𝘰𝘶𝘳 𝘤𝘶𝘭𝘵𝘶𝘳𝘦!”

This week, we celebrated Earth Day with a few green initiatives. Taking the time for intentional connection, space to create, and recharge as a team.

We hosted our first Great Book Exchange while sharing stories and giving pre-loved books a new home.

Staff enjoyed getting their artistic juices flowing through painting flowerpots and planting new life to brighten our workspace.

Address

Torrey Pines Science Park 11025 N Torrey Pines Road #200
La Jolla, CA
92037

Website

https://inhibrx.com/

Alerts

Be the first to know and let us send you an email when Inhibrx Biosciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Business in La Jolla?